These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8564320)

  • 21. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Soto S; Knapp E
    Acta Psychiatr Scand; 1993 Jul; 88(1):1-11. PubMed ID: 8372689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
    Pohl R; Balon R; Yeragani VK; Gershon S
    Psychopathology; 1989; 22 Suppl 1():60-7. PubMed ID: 2657839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive-behavioral therapy of panic disorder with secondary major depression: a preliminary investigation.
    Laberge B; Gauthier JG; Côté G; Plamondon J; Cormier HJ
    J Consult Clin Psychol; 1993 Dec; 61(6):1028-37. PubMed ID: 8113480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applied relaxation vs cognitive behavior therapy in the treatment of panic disorder.
    Ost LG; Westling BE
    Behav Res Ther; 1995 Feb; 33(2):145-58. PubMed ID: 7887873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia.
    Bouchard S; Gauthier J; Laberge B; French D; Pelletier MH; Godbout C
    Behav Res Ther; 1996 Mar; 34(3):213-24. PubMed ID: 8881091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discussion of "methodological controversies in the treatment of panic disorder".
    Klein DF
    Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
    [No Abstract]   [Full Text] [Related]  

  • 28. Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia.
    van den Hout M; Arntz A; Hoekstra R
    Behav Res Ther; 1994 May; 32(4):447-51. PubMed ID: 7910732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
    Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V
    J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transporting an empirically supported treatment for panic disorder to a service clinic setting: a benchmarking strategy.
    Wade WA; Treat TA; Stuart GL
    J Consult Clin Psychol; 1998 Apr; 66(2):231-9. PubMed ID: 9583326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.
    Vos SP; Huibers MJ; Diels L; Arntz A
    Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a specific model for cognitive-behavioral therapy among panic disorder patients with agoraphobia: a randomized clinical trial.
    King AL; Valença AM; de Melo-Neto VL; Freire RC; Mezzasalma MA; Silva AC; Nardi AE
    Sao Paulo Med J; 2011; 129(5):325-34. PubMed ID: 22069132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of personality disorder on the treatment of panic disorder--comparison study.
    Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia.
    Westra HA; Stewart SH; Conrad BE
    J Anxiety Disord; 2002; 16(3):233-46. PubMed ID: 12214810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Integrated treatment strategies in panic disorder with agoraphobia and depressive disorder].
    Boerner RJ
    Nervenarzt; 1995 Mar; 66(3):212-6. PubMed ID: 7753246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy.
    McLean PD; Woody S; Taylor S; Koch WJ
    J Consult Clin Psychol; 1998 Apr; 66(2):240-7. PubMed ID: 9583327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive and Guided Mastery Therapies for Panic Disorder with Agoraphobia: 18-Year Long-Term Outcome and Predictors of Long-Term Change.
    Hoffart A; Hedley LM; Svanøe K; Sexton H
    Clin Psychol Psychother; 2016; 23(1):1-13. PubMed ID: 25452222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpidem in the treatment of panic disorder.
    Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.